Tumor Biology

, Volume 37, Issue 2, pp 2443–2448 | Cite as

Identification of a shared protective genetic susceptibility locus for colorectal cancer and gastric cancer

  • Na He
  • Lijun Liu
  • Xianglong Duan
  • Li Wang
  • Dongya Yuan
  • Tianbo Jin
  • Longli Kang
Original Article


Risk of both colorectal cancer (CRC) and gastric cancer (GC) is considered to be heritable with mounting evidence for their genetic susceptibility. However, it remains unknown whether a shared genetic background is underlying these two cancers. A total of ten single nucleotide polymorphisms (SNPs) associated with digestive system cancers risk were selected from previous genome-wide association studies. All SNPs were genotyped in 449 CRC cases, 588 GC cases, and 703 controls using Sequenom Mass-ARRAY technology. Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were estimated using unconditional logistic regression analysis with adjustment for age and gender, and evaluated their association with both cancers in a Han Chinese population using chi-squared (χ 2) test and genetic model analysis. By χ 2 test, we found that rs2057314 (p = 0.028; OR = 1.21) was significantly associated with an increased risk of CRC, rs7758229 (p = 0.005; OR = 0.77) was significantly associated with a decreased risk of GC. Furthermore, a shared susceptibility locus rs9502893 was found to have significant protective effect against CRC (p = 0.010; OR = 0.80) and GC (p = 0.0003; OR = 0.74). Our findings could provide insight into the underlying shared a partly overlapping genetic aspect of CRC and GC in a Chinese population. Additional studies are required to verify and discover more common genetic variants associated with risk for digestive system cancers.


Colorectal cancer Gastric cancer Single nucleotide polymorphism Susceptibility 



This work is supported by the Key Program of Natural Science Foundation of Xizang (Tibet) Autonomous Region (20152R-13-11) and Major Training Program of Tibet University for Nationalities (No. 13myZP06).

Conflicts of interest



  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMedGoogle Scholar
  2. 2.
    Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–78.CrossRefPubMedGoogle Scholar
  3. 3.
    Li X, Yang XX, Hu NY, Sun JZ, Li FX, Li M. A risk-associated single nucleotide polymorphism of smad7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Mol Biol Rep. 2011;38:5093–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Li FX, Yang XX, He XQ, Hu NY, Wu YS, Li M. Association of 10q23 with colorectal cancer in a Chinese population. Mol Biol Rep. 2012;39:9557–62.CrossRefPubMedGoogle Scholar
  5. 5.
    Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ. Genome-wide association studies in cancer--current and future directions. Carcinogenesis. 2010;31:111–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology. 2013;144:e724–807.CrossRefGoogle Scholar
  7. 7.
    Jiao S, Hsu L, Berndt S, Bezieau S, Brenner H, Buchanan D, et al. Genome-wide search for gene-gene interactions in colorectal cancer. PLoS One. 2012;7:e52535.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 2012;44:62–6.CrossRefGoogle Scholar
  9. 9.
    Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y, et al. Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet. 2012;91:928–34.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, et al. Common variation near cdkn1a, pold3 and shroom2 influences colorectal cancer risk. Nat Genet. 2012;44:770–6.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet. 2011;43:679–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Cui R, Okada Y, Jang SG, Ku JL, Park JG, Kamatani Y, et al. Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut. 2011;60:799–805.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Low SK, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One. 2010;5:e11824.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Inui KI, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 2000;58:944–58.CrossRefPubMedGoogle Scholar
  15. 15.
    Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, et al. Park2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in apc mutant mice. Proc Natl Acad Sci U S A. 2010;107:15145–50.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A. 2003;100:5956–61.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Castellanos A, Lang G, Frampton J, Weston K. Regulation of erythropoiesis by the neuronal transmembrane protein lrfn2. Exp Hematol. 2007;35:724–34.CrossRefPubMedGoogle Scholar
  18. 18.
    Gabriel S, Ziaugra L, Tabbaa D: Snp genotyping using the sequenom massarray iplex platform. Current protocols in human genetics / editorial board, Jonathan L Haines [et al.] 2009;Chapter 2:Unit 2.12.Google Scholar
  19. 19.
    Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.CrossRefPubMedGoogle Scholar
  20. 20.
    Adamec C. Example of the use of the nonparametric test. Test x2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.PubMedGoogle Scholar
  21. 21.
    Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ (Clinical research ed). 2000;320:1468.CrossRefGoogle Scholar
  22. 22.
    Myatt SS, Lam EW. The emerging roles of forkhead box (fox) proteins in cancer. Nat Rev Cancer. 2007;7:847–59.CrossRefPubMedGoogle Scholar
  23. 23.
    Hannenhalli S, Kaestner KH. The evolution of fox genes and their role in development and disease. Nat Rev Genet. 2009;10:233–40.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Kang BW, Jeon HS, Chae YS, Lee SJ, Park JY, Choi JE, et al. Association between gwas-identified genetic variations and disease prognosis for patients with colorectal cancer. PLoS One. 2015;10:e0119649.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (oct3) most abundantly expressed in placenta. J Biol Chem. 1998;273:15971–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Shnitsar V, Eckardt R, Gupta S, Grottker J, Muller GA, Koepsell H, et al. Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine. Cancer Res. 2009;69:1494–501.CrossRefPubMedGoogle Scholar
  27. 27.
    Yokoo S, Masuda S, Yonezawa A, Terada T, Katsura T, Inui K. Significance of organic cation transporter 3 (slc22a3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer. Drug Metabolism and disposition. 2008;36:2299–306.CrossRefPubMedGoogle Scholar
  28. 28.
    Zhu L, Du M, Gu D, Ma L, Chu H, Tong N, et al. Genetic variant rs7758229 in 6q26-q27 is not associated with colorectal cancer risk in a Chinese population. PLoS One. 2013;8:e59256.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Yang CH, Chuang LY, Chen YJ, Tseng HF, Chang HW. Computational analysis of simulated snp interactions between 26 growth factor-related genes in a breast cancer association study. Omics. 2011;15:399–407.CrossRefPubMedGoogle Scholar
  30. 30.
    Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, et al. Combinational polymorphisms of seven cxcl12-related genes are protective against breast cancer in Taiwan. Omics. 2009;13:165–72.CrossRefPubMedGoogle Scholar
  31. 31.
    Chen JB, Chuang LY, Lin YD, Liou CW, Lin TK, Lee WC, et al. Preventive snp-snp interactions in the mitochondrial displacement loop (d-loop) from chronic dialysis patients. Mitochondrion. 2013;13:698–704.CrossRefPubMedGoogle Scholar
  32. 32.
    Bei CH, Bai H, Yu HP, Yang Y, Liang QQ, Deng YY, et al. Combined effects of six cytokine gene polymorphisms and snp-snp interactions on hepatocellular carcinoma risk in southern Guangxi, China. Asian Pacific Journal Cancer Prevention. 2014;15:6961–7.CrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Key Laboratory of High Altitude Environment and Genes Related to Diseases of the Tibet Autonomous Region, School of MedicineXizang Minzu UniversityXianyangChina
  2. 2.Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Diseases of the Tibet Autonomous Region, School of MedicineXizang Minzu UniversityXianyangChina
  3. 3.Department of General Surgery, People’s Hospital of Shaanxi ProvinceXi’anChina
  4. 4.School of Life SciencesNorthwest UniversityXi’anChina

Personalised recommendations